google-site-verification: googlef34d17771a9ef049.html Blog | cba-consulting
  • LinkedIn Social Icon

© 2017 by Cambridge Biostrategy Associates LLC. Proudly created with Wix.com

Please reload

Follow Us

September 19, 2017

In my previous blog post, I suggested that the market size for gene-modified T-cell therapies would be roughly $9 Bn in 10 years, with a range of around $5 - $20 Bn. In this post I will provide some structure for this wide range by breaking out five key factors that wi...

September 13, 2017

Over the last two months, several news events have brought CAR-T cells to widespread public attention, the most prominent of which is the FDA approval of the first gene-modified cell therapy, for children with a type of leukemia who have failed other options. The new t...

Please reload

  • LinkedIn Social Icon
Please reload

Recent Posts
Search By Tags
Featured Posts

Artificial intelligence in pharma, health care is at the crossroads of hype and reality

December 7, 2018

1/6
Please reload

Archive
Please reload